2026 ASCO: Navigating the Era of Adoptive Cellular Therapy and Finite-Duration Regimens in Advanced Malignancies

from TheBrief.Health · host TheBrief.Health

A fundamental shift is underway in advanced oncology: the move from continuous, 'treat-to-progression' regimens to high-efficacy, finite-duration protocols. This evolution redefines long-term patient management and offers new potential for durable, treatment-free responses.

Episode metadata supplied by the publisher feed · Published Jun 4, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

2026 ASCO: Navigating the Era of Adoptive Cellular Therapy and Finite-Duration Regimens in Advanced Malignancies

0:00 1:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 4, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!